These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydration and N-acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats. Pinto CF; Watanabe M; Vattimo Mde F J Nephrol; 2008; 21(5):783-8. PubMed ID: 18949735 [TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844 [TBL] [Abstract][Full Text] [Related]
4. N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Haase M; Haase-Fielitz A; Ratnaike S; Reade MC; Bagshaw SM; Morgera S; Dragun D; Bellomo R Nephrol Dial Transplant; 2008 May; 23(5):1581-7. PubMed ID: 18202091 [TBL] [Abstract][Full Text] [Related]
8. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332 [TBL] [Abstract][Full Text] [Related]
9. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions. Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692 [TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity. Abdelrahman AM; Al Salam S; AlMahruqi AS; Al husseni IS; Mansour MA; Ali BH J Appl Toxicol; 2010 Jan; 30(1):15-21. PubMed ID: 19681060 [TBL] [Abstract][Full Text] [Related]
11. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Trivedi H; Daram S; Szabo A; Bartorelli AL; Marenzi G Am J Med; 2009 Sep; 122(9):874.e9-15. PubMed ID: 19699385 [TBL] [Abstract][Full Text] [Related]
12. Novel approach for the prevention of contrast nephropathy. Colbay M; Yuksel S; Uslan I; Acarturk G; Karaman O; Bas O; Mollaoglu H; Yagmurca M; Ozen OA Exp Toxicol Pathol; 2010 Jan; 62(1):81-9. PubMed ID: 19327972 [TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? Shalansky SJ; Vu T; Pate GE; Levin A; Humphries KH; Webb JG Pharmacotherapy; 2005 Aug; 25(8):1095-103. PubMed ID: 16207100 [TBL] [Abstract][Full Text] [Related]
14. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study. Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691 [TBL] [Abstract][Full Text] [Related]
15. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents]. Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695 [TBL] [Abstract][Full Text] [Related]
16. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303 [TBL] [Abstract][Full Text] [Related]
17. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497 [TBL] [Abstract][Full Text] [Related]